Back to Search
Start Over
Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
- Source :
-
Oncogene [Oncogene] 2004 May 27; Vol. 23 (25), pp. 4466-76. - Publication Year :
- 2004
-
Abstract
- Activation of the transcription factor AP-1 (activator protein-1) is required for tumor promotion and maintenance of malignant phenotype. A number of AP-1-regulated genes that play a role in tumor progression have been identified. However, AP-1-regulated genes driving tumor induction are yet to be defined. Previous studies have established that expression of a dominant-negative c-Jun (TAM67) inhibits phorbol 12-tetradecanoyl-13-acetate (TPA)-induced AP-1 transactivation as well as transformation in mouse epidermal JB6/P+ cells and tumor promotion in mouse skin carcinogenesis. In this study, we utilized the tumor promotion-sensitive JB6/P+ cells to identify AP-1-regulated TAM67 target genes and to establish causal significance in transformation for one target gene. A 2700 cDNA microarray was queried with RNA from TPA-treated P+ cells with or without TAM67 expression. Under conditions in which TAM expression inhibited TPA-induced transformation, microarray analysis identified a subset of six genes induced by TPA and suppressed by TAM67. One of the identified genes, the high-mobility group protein A1 (Hmga1) is induced by TPA in P+, but not in transformation-resistant P cells. We show that TPA induction of the architectural transcription factor HMGA1 is inhibited by TAM67, is extracellular-signal-regulated kinase (ERK)-activation dependent, and is mediated by AP-1. HMGA1 antisense construct transfected into P+ cells blocked HMGA1 protein expression and inhibited TPA-induced transformation indicating that HMGA1 is required for transformation. HMGA1 is not however sufficient as HMGA1a or HMGA1b overexpression did not confer transformation sensitivity on P- cells. Although HMGA1 expression is ERK dependent, it is not the only ERK-dependent event required for transformation because it does not suffice to rescue ERK-deficient P- cells. Our study shows (a) TAM 67 when it inhibits AP-1 and transformation, targets a relatively small number of genes; (b) HMGA1, a TAM67 target gene, is causally related to transformation and therefore a potentially important target for cancer prevention.
- Subjects :
- Animals
Butadienes pharmacology
Cell Line drug effects
Cell Line metabolism
Cell Transformation, Neoplastic drug effects
Clone Cells drug effects
Clone Cells metabolism
Cyclin D1 biosynthesis
Cyclin D1 genetics
DNA, Complementary genetics
Disease Susceptibility
Epidermis drug effects
Epidermis metabolism
Gene Expression Profiling
MAP Kinase Kinase Kinases antagonists & inhibitors
MAP Kinase Signaling System
Mice
Mice, Transgenic
Mitogen-Activated Protein Kinase 1 physiology
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinases physiology
Nitriles pharmacology
Oligonucleotide Array Sequence Analysis
Oligonucleotides, Antisense pharmacology
Osteopontin
Proto-Oncogene Proteins c-jun deficiency
Sialoglycoproteins biosynthesis
Sialoglycoproteins genetics
Tetradecanoylphorbol Acetate toxicity
Transcription Factor AP-1 physiology
Transcription, Genetic drug effects
Cell Transformation, Neoplastic genetics
Epidermal Cells
Genes, jun genetics
HMGA1a Protein physiology
HMGA1b Protein physiology
MAP Kinase Kinase Kinase 1
Proto-Oncogene Proteins c-jun physiology
Transcription, Genetic genetics
Subjects
Details
- Language :
- English
- ISSN :
- 0950-9232
- Volume :
- 23
- Issue :
- 25
- Database :
- MEDLINE
- Journal :
- Oncogene
- Publication Type :
- Academic Journal
- Accession number :
- 15064752
- Full Text :
- https://doi.org/10.1038/sj.onc.1207581